IndraLab
Statements
reach
"These results show that celastrol may inhibit NLRP3 inflammasome to protect against PD via Nrf2, indicating that Nrf2-NLRP3-caspase-1 axis may underlie the favorable effects of celastrol in PD treatment.The hallmark of PD is the loss of dopaminergic neurons [6,9,57,[62], [63], [64]]."
reach
"However, whether the celastrol inhibits NLRP3 inflammasome through Nrf2 to exert neuroprotective effects in PD is not yet known.To assess the neuroprotective actions of celastrol in PD, we employed multiple PD models to better understand the nigro-striatal degeneration, including MPTP-induced PD mouse model and the AAV-mediated human α-syn overexpression PD model."
reach
"In vivo experiments have demonstrated that autophagy inhibition ameliorated celastrol-mediated NLRP3 inflammasome suppression in LPS-induced septic shock or dextran sodium sulfate (DSS)-induced colitis mouse models, thereby indicating that autophagy may be responsible for the protection against NLRP3-related diseases exerted by celastrol (33)."